TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T15971 XX ID T15971 XX DT 12.05.2009 (created); pro. DT 20.03.2015 (updated); jtr. CO Copyright (C), QIAGEN. XX FA NFkappaB XX SY NFkappaB; Nuclear Factor kappa B. XX OS rat, Rattus norvegicus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX IN T04494 FXR; rat, Rattus norvegicus. XX BS R20825. BS R26202. BS R56324. BS R19783. BS R00877. BS R29147. BS R32472. BS R41762. BS R32886. BS R32887. BS R66862. BS R59875. BS R27535. BS R27539. BS R29604. BS R61627. BS R35696. BS R59883. XX DR TRANSPATH: MO000158005. XX RN [1]; RE0079199. RX PUBMED: 23124354. RA Catalano S., Panza S., Malivindi R., Giordano C., Barone I., Bossi G., Lanzino M., Sirianni R., Mauro L., Sisci D., Bonofiglio D., Ando S. RT Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy. RL Int. J. Cancer 132:2237-2247 (2013). XX //